Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Oncofertility w praktyce klin.
  • Obniżka
Oxford Textbook of Critical Care

Oxford Textbook of Critical Care

9780198855439
1 333,80 zł
1 200,42 zł Zniżka 133,38 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 1 200,42 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis
Now in paperback, the second edition of the Oxford Textbook of Critical Care is a comprehensive multi-disciplinary text covering all aspects of adult intensive care management. Uniquely this text takes a problem-orientated approach providing a key resource for daily clinical issues in the intensive care unit.The text is organized into short topics allowing readers to rapidly access authoritative information on specific clinical problems. Each topic refers to basic physiological principles and provides up-to-date treatment advice supported by references to the most vital literature. Where international differences exist in clinical practice, authors cover alternative views. Key messages summarise each topic in order to aid quick review and decision making.Edited and written by an international group of recognized experts from many disciplines, the second edition of the Oxford Textbook of Critical Careprovides an up-to-date reference that is relevant for intensive care units and emergency departments globally. This volume is the definitive text for all health care providers, including physicians, nurses, respiratory therapists, and other allied health professionals who take care of critically ill patients.
Szczegóły produktu
OUP Oxford
88458
9780198855439
9780198855439

Opis

Rok wydania
2019
Numer wydania
2
Oprawa
miękka foliowana
Liczba stron
1960
Wymiary (mm)
219 x 276
Waga (g)
3820
  • Section 1: ICU Organisation and Management: The Intensive Care Unit; Part 1.1: The Intensive Care Unit; Design of the ICU; Staffing models in the ICU; Rapid response teams for the critically ill; In-hospital transfer of the critically ill; Pre- and inter-hospital transfer of the critically ill and injured; Regional critical care delivery systems; Integration of information technology in the ICU; Multiple casualties and disaster response in critical care; Management of pandemic critical illness; Part 1.2: Communication; Effective teamwork in the ICU; Communication with patients and families in the ICU; Telemedicine in critical care; Part 1.3: Training; Clinical skills in critical care; Simulation training for critical care; Leadership skills in the ICU; Part 1.4: Safety and Quality; Patient safety in the ICU; Policies, bundles and protocols in critical care; Managing biohazards and environmental safety; Managing ICU staff welfare, morale and burnout; Part 1.5: Governance; ICU admission and discharge criteria; Resource management and budgeting in critical care; Costs and cost-effectiveness in critical care; Part 1.6: Research; Evidence-based practice in critical care; Research ethics in the ICU; Part 1.7: Medico-legal and ethical issues; Informed consent in the ICU; Patient rights in the ICU; Medico-legal liability in critical care; Part 1.8: Critical Illness Risk Prediction; The role and limitations of scoring systems; Severity of illness scoring systems; Organ failure scoring; Genetic and molecular expression patterns in critical illness; Section 2: Pharmacotherapeutics; Part 2.1: Respiratory drugs; Oxygen in critical illness; Bronchodilators in critical illness; Vasopressors in critical illness; Vasodilators in critical illness; Inotropic agents in critical illness; Anti-anginal agents in critical illness; Anti-arrhythmics in critical illness; Pulmonary vasodilators in critical illness; Part 2.3: Gastrointestinal drugs; Gastrointestinal motility drugs in critical illness; Stress ulcer prophylaxis and treatment drugs in critical illness; Part 2.4: Nervous system drugs; Sedatives and anti-anxiety agents in critical illness; Analgesics in critical illness; Antidepressants in critical illness; Antiseizure agents in critical illness; Inhalational anaesthetic agents in critical illness; Muscle relaxants in critical illness; Neuroprotective agents in critical illness; Part 2.5: Hormonal drugs; Hormone therapies in critical illness; Insulin and oral anti-hyperglycaemic agents in critical illness; Part 2.6: Haematological drugs; Anticoagulants and antithrombotics in critical illness; Haemostatic agents in critical illness; Part 2.7: Antimicrobial and immunological drugs; Antimicrobial drugs in critical illness; Steroids in critical illness; Immunotherapy in critical illness; Part 2.8: Fluids and diuretics; Colloids in critical illness; Crystalloids in critical illness; Diuretics in critical illness; Section 3: Resuscitation; Part 3.1: Respiratory management; Airway management in cardiopulmonary resuscitation; Artificial ventilation in cardiopulmonary resuscitation; Part 3.2: Circulatory management; Pathophysiology and causes of cardiac arrest; Cardiac massage and blood flow management during cardiac arrest; Defibrillation and pacing during cardiac arrest; Therapeutic strategies in managing cardiac arrest; Post-cardiac arrest arrhythmias; Management after resuscitation from cardiac arrest; Ethical and end-of-life issues after cardiac arrest; Part 3.3: Fluid Management; Physiology of body fluids; Choice of resuscitation fluid; Therapeutic goals of fluid resuscitation; Section 4: The Respiratory System; Part 4.1: Physiology; Normal physiology of the respiratory system; Part 4.2: Respiratory monitoring; Blood gas analysis in the critically ill; Pulse oximetry and capnography in the ICU; Respiratory system compliance and resistance in the critically ill; Gas exchange principles in the critically ill; Gas exchange assessment in the critically ill; Respiratory muscle function in the critically ill; Imaging the respiratory system in the critically ill; Part 4.3: Upper airway obstruction; Upper airway obstruction in the critically ill; Part 4.4: Airway access; Standard intubation in the ICU; The difficult intubation in the ICU; The surgical airway in the ICU; Part 4.5: Acute respiratory failure; Dyspnoea in the critically ill; Pulmonary mechanical dysfunction in the critically ill; Hypoxaemia in the critically ill; Hypercapnia in the critically ill; Cardiovascular interactions in respiratory failure; Part 4.6: Ventilatory support; Physiology of positive-pressure ventilation; Respiratory support with continuous positive airways pressure; Non-invasive positive-pressure ventilation; Indications for mechanical ventilation; Design and function of mechanical ventilators; Setting rate, volume, and time in ventilatory support; Respiratory support with positive end-expiratory pressure; Volume-controlled mechanical ventilation; Pressure-controlled mechanical ventilation; Pressure support ventilation; High-frequency ventilation and oscillation; Prone positioning in the ICU; Failure to ventilate in critical illness; Ventilator trauma in the critically ill; Part 4.7: Weaning ventilatory support; Assessment and technique of weaning; Weaning failure in critical illness; Part 4.8: Extracorporeal support; Extracorporeal respiratory and cardiac support techniques in the ICU; Treating respiratory failure with extracorporeal support in the ICU; Part 4.9: Aspiration and inhalation; Aspiration of gastric contents in the critically ill; Inhalation injury in the ICU; Part 4.10: Acute respiratory distress syndrome; Pathophysiology of acute respiratory distress syndrome; Therapeutic strategy in acute respiratory distress syndrome; Part 4.11: Airflow limitation; Pathophysiology and causes of airflow limitation; Therapeutic approach to bronchospasm and asthma; Therapeutic strategy in acute or chronic airflow limitation; Part 4.12: Respiratory acidosis and alkalosis; Pathophysiology and therapeutic strategy of respiratory acidosis; Pathophysiology and therapeutic strategy of respiratory alkalosis; Part 4.13: Pneumonia; Pathophysiology of pneumonia; Diagnosis and management of community-acquired pneumonia; Diagnosis and management of nosocomial pneumonia; Diagnosis and management of atypical pneumonia; Part 4.14: Atelectasis and sputum retention; Pathophysiology and prevention of sputum retention; Lung recruitment techniques in the ICU; Chest physiotherapy and tracheobronchial suction in the ICU; Toilet bronchoscopy in the ICU; Part 4.15: Pleural cavity disorders; Pathophysiology of pleural cavity disorders; Management of pneumothorax and bronchial fistulae; Management of pleural effusion and haemothorax; Part 4.16: Hemoptysis; Pathophysiology and causes of haemoptysis; Therapeutic approach in haemoptysis; Section 5: The Cardiovascular System; Part 5.1: Physiology; Normal physiology of the cardiovascular system; Part 5.2: Cardiovascular monitoring; ECG monitoring in the ICU; Arterial and venous cannulation in the ICU; Blood pressure monitoring in the ICU; Central venous pressure monitoring in the ICU; Pulmonary artery catheterization in the ICU; Mixed and central venous oxygen saturation monitoring in the ICU; Right ventricular function in the ICU; Cardiac output assessment in the ICU; Oxygen transport in the critically ill; Tissue perfusion monitoring in the ICU; Lactate monitoring in the ICU; Measurement of extravascular lung water in the ICU; Doppler echocardiography in the ICU; Monitoring the microcirculation in the ICU; Imaging the cardiovascular system in the ICU; Part 5.3: Acute chest pain and coronary syndromes; Causes and diagnosis of chest pain; Pathophysiology of coronary syndromes; Diagnosis and management of non-STEMI coronary syndromes; Diagnosis and management of ST-elevation myocardial infarction; Part 5.4: Aortic dissection; Pathophysiology, diagnosis, and management of aortic dissection; Part 5.5: The hypotensive patient; Pathophysiology of shock; Diagnosis and management of shock in the ICU; Part 5.6: Cardiac failure; Pathophysiology and causes of cardiac failure; Therapeutic strategy in cardiac failure; Intra-aortic balloon counterpulsation in the ICU; Ventricular assist devices in the ICU; Part 5.7: Tachyarrhythmias; Causes and diagnosis of tachyarrythmias; Therapeutic strategy in tachyarrhythmias; Part 5.8: Bradyarrhythmias; Causes, diagnosis and therapeutic strategy in bradyarrhythmias; Part 5.9: Valvular problems; Causes and diagnosis of valvular problems; Therapeutic strategy in valvular problems; Part 5.10: Endocarditis; Pathophysiology and causes of endocarditis; Prevention and treatment of endocarditis; Part 5.11: Severe hypertension; Pathophysiology and causes of severe hypertension; Management of severe hypertension in the ICU; Part 5.12: Severe capillary leak; Pathophysiology of severe capillary leak; Management of acute non-cardiogenic pulmonary oedema; Part 5.13: Pericardial tamponade; Pathophysiology and causes of pericardial tamponade; Management of pericardial tamponade; Part 5.14: Pulmonary hypertension; Pathophysiology and causes of pulmonary hypertension; Diagnosis and management of pulmonary hypertension; Part 5.15: Pulmonary embolus; Pathophysiology and causes of pulmonary embolus; Diagnosis and management of pulmonary embolus; Section 6: The Gastrointestinal System; Part 6.1: Physiology; Normal physiology of the gastrointestinal system; Normal physiology of the hepatic system; Part 6.2: Gastrointestinal monitoring; Imaging the abdomen in the critically ill; Hepatic function in the critically ill; Part 6.3: Gastrointestinal haemorrhage; Pathophysiology and causes of upper gastrointestinal haemorrhage; Diagnosis and management of upper gastrointestinal haemorrhage in the critically ill; Diagnosis and management of variceal bleeding in the critically ill; Pathophysiology and causes of lower gastrointestinal haemorrhage; Diagnosis and management of lower gastrointestinal haemorrhage in the critically ill; Part 6.4: Disordered gastric motility; Vomiting and large nasogastric aspirates in the critically ill; Ileus and obstruction in the critically ill; Diarrhoea and constipation in the critically ill; Part 6.5: The acute abdomen in the ICU; Pathophysiology and management of raised intra-abdominal pressure in the critically ill; Perforated viscus in the critically ill; Ischaemic bowel in the critically ill; Intra-abdominal sepsis in the critically ill; Acute acalculous cholecystitis in the critically ill; Management of the open abdomen and abdominal fistulae in the critically ill; Part 6.6: Pancreatitis; Pathophysiology, diagnosis and assessment of acute pancreatitis; Management of acute pancreatitis in the critically ill; Part 6.7: Jaundice; Pathophysiology and causes of jaundice in the critically ill; Management of jaundice in the critically ill; Part 6.8: Acute hepatic failure; Pathophysiology and causes of acute hepatic failure; Diagnosis and assessment of acute hepatic failure in the critically ill; Management of acute hepatic failure in the critically ill; The effect of acute hepatic failure on drug handling in the critically ill; Extracorporeal liver support devices in the ICU; Part 6.9: Acute on chronic hepatic failure; 199: Pathophysiology, diagnosis, assessment of acute or chronic hepatic failure; Management of acute or chronic hepatic failure in the critically ill; Section 7: Nutrition; Part 7.1: Physiology; Normal physiology of nutrition; The metabolic and nutritional response to critical illness; Part 7.2: Nutritional failure; Pathophysiology of nutritional failure in the critically ill; Assessing nutritional status in the ICU; Indirect calorimetry in the ICU; Enteral nutrition in the ICU; Parenteral nutrition in the ICU; Section 8: The Renal System; Part 8.1: Physiology; Normal physiology of the renal system; Part 8.2: Renal monitoring and risk prediction; Monitoring renal function in the critically ill; Imaging the urinary tract in the critically ill; Part 8.3: Oliguria and acute kidney injury; Pathophysiology of oliguria and acute kidney injury; Diagnosis of oliguria and acute kidney injury; Management of oliguria and acute kidney injury in the critically ill; Part 8.4: Renal replacement techniques; Continuous haemofiltration techniques in the critically ill; Haemodialysis in the critically ill; Peritoneal dialysis in the critically ill; Part 8.5: Established renal failure; The effect of renal failure on drug handling in critical illness; The effect of chronic renal failure on critical illness; Section 9: The Neurological System; Part 9.1: Anatomy and physiology; Normal anatomy and physiology of the brain; Normal anatomy and physiology of the spinal cord and peripheral nerves; Part 9.2: Neurological monitoring; Electroencephalogram monitoring in the critically ill; Cerebral bloodflow and perfusion monitoring in the critically ill; Intracranial pressure monitoring in the ICU; Imaging the central nervous system in the critically ill; Part 9.3: Sleep disturbance; Pathophysiology and therapeutic strategy for sleep disturbance in the ICU; Part 9.4: Agitation, confusion and delirium; Causes and epidemiology of agitation, confusion and delirium in the ICU; Assessment and therapeutic strategy for agitation, confusion and delirium in the ICU; Part 9.5: The unconscious patient; Causes and diagnosis of unconsciousness; Management of unconsciousness in the ICU; Non-pharmacological neuroprotection in the ICU; Part 9.6: Seizures; Pathophysiology and causes of seizures; Assessment and management of seizures in the critically ill; Part 9.7: Intracranial hypertension; Causes and management of intracranial hypertension; Part 9.8: Stroke; Epidemiology of stroke; Diagnosis and assessment of stroke; Management of ischaemic stroke; Management of parenchymal haemorrhage; Part 9.9: Non-traumatic subarachnoid haemorrhage; Epidemiology, diagnosis, and assessment on non-traumatic subarachnoid haemorrhage; Management of non-traumatic subarachnoid haemorrhage in the critically ill; Part 9.10: Meningitis and encephalitis; Epidemiology, diagnosis and assessment of meningitis and encephalitis; Management of meningitis and encephalitis in the critically ill; Part 9.11: Non-traumatic spinal injury; Pathophysiology, causes, and management of non-traumatic spinal injury; Part 9.12: Neuromuscular syndromes; Epidemiology, diagnosis, and assessment of neuromuscular syndromes; Diagnosis, assessment, and management of myasthenia gravis and paramyasthenic syndromes; Diagnosis, assessment, and management of tetanus, rabies and botulism; Diagnosis, assessment, and management of Guillain-Barre syndrome; Diagnosis, assessment, and management of hyperthermic crises; Diagnosis, assessment, and management of ICU acquired weakness; Section 10: The Metabolic and Endocrine Systems; Part 10.1: Physiology; Normal physiology of the endocrine system; Part 10.2: Electrolyte disturbance; Disorders of sodium in the critically ill; Disorders of potassium in the critically ill; Disorders of magnesium in the critically ill; Disorders of calcium in the critically ill; Disorders of phosphate in the critically ill; Part 10.3: Metabolic acidosis and alkalosis; Pathophysiology and causes of metabolic acidosis in the critically ill; Management of metabolic acidosis in the critically ill; Pathophysiology, causes, and management of metabolic alkalosis in the critically ill; Part 10.4: Blood glucose control; Pathophysiology of glucose control; Glycaemic control in critical illness; Management of diabetic emergencies in the critically ill; Part 10.5: Endocrine disorders; Pathophysiology and management of adrenal disorders in the critically ill; Pathophysiology and management of pituitary disorders in the critically ill; Pathophysiology and management of thyroid disorders in the critically ill; Pathophysiology and management of functional endocrine tumours in the critically ill; Section 11: The Haematological System; Part 11.1: Laboratory monitoring; The blood cells and blood count; Coagulation monitoring; Part 11.2: Haematological therapies; Blood product therapy in the ICU; Apheresis in the ICU; Part 11.3: Disordered coagulation; Pathophysiology of disordered coagulation; Disseminated intravascular coagulation in the critically ill; Prevention and management of thrombosis in the critically ill; Thrombocytopenia in the critically ill; Part 11.4: Disorders of the blood cells; Pathophysiology and management of anaemia in the critically ill; Pathophysiology and management of neutropenia in the critically ill; Sickle crisis in the critically ill; Section 12: The Skin and Connective Tissue; Part 12.1: Skin and connective tissue disorders; Assessment and management of dermatological problems in the critically ill; Vasculitis in the critically ill; Rheumatoid arthritis in the critically ill; Part 12.2: Wound and pressure sore management; Principles and prevention of pressure sores in the ICU; Dressing techniques for wounds in the critically ill; Section 13: Infection; Part 13.1: Diagnosis and surveillance; Microbiological surveillance in the critically ill; Novel biomarkers of infection in the critically ill; Part 13.2: Nosocomial infection; Definition, epidemiology and general management of nosocomial infection; Healthcare worker screening for nosocomial pathogens; Environmental decontamination and isolation strategies in the ICU; Antimicrobial selection policies in the ICU; Oral, nasopharyngeal and gut decontamination in the ICU; Diagnosis, prevention, and treatment of device-related infection in the ICU; Antibiotic resistance in the ICU; Part 13.3: Infection in the immunocompromised; Drug-induced depression of immunity in the critically ill; HIV in the critically ill; Part 13.4: Tropical diseases; Diagnosis and management of malaria in the ICU; Diagnosis and management of viral haemorrhagic fevers in the ICU; Other tropical diseases in the ICU; Part 13.5: Sepsis; Assessment of sepsis in the critically ill; Management of sepsis in the critically ill; Pathophysiology of septic shock; Management of septic shock in the critically ill; Section 14: Inflammation; Part 14.1: Physiology; Innate immunity and the inflammatory cascade; Part 14.2: Organ-specific biomarkers; Brain injury biomarkers in the critically ill; Cardiac injury biomarkers in the critically ill; Renal injury biomarkers in the critically ill; Part 14.3: Host response; The host response to infection in the critically ill; The host response to trauma and burns in the critically ill; The host response to hypoxia in the critically ill; Host-pathogen interactions in the critically ill; Coagulation and the endothelium in acute injury in the critically ill; Ischemia-reperfusion injury in the critically ill; Repair and recovery mechanisms following critical illness; Neural and endocrine function in the immune response to critical illness; Adaptive immunity in critical illness; Immunomodulation strategies in the critically ill; Immunoparesis in the critically ill; Part 14.4: Anaphylaxis; Pathophysiology and management of anaphylaxis in the critically ill; Section 15: Poisoning; Part 15.1: Principles of management; Role of toxicology assessment in poisoning; Decontamination and enhanced elimination of poisons; Part 15.2: Management of specific poisons; Management of salicylate poisoning; Management of acetaminophen (paracetamol) poisonin; Management of opioid poisoning; Management of benzodiazepine poisoning; Management of tricyclic antidepressant poisoning; Management of amphetamine or ecstasy; Management of digoxin poisoning; Management of cocaine poisoning; Management of beta-blocker and calcium channel blocker poisoning; Management of cyanide poisoning; Management of alcohol poisoning; Management of carbon monoxide poisoning; Management of corrosive poisoning; Management of pesticide and agricultural chemical poisoning; Management of radiation poisoning; Section 16: Trauma; Part 16.1: Multiple trauma; A systematic approach to the injured patient; Pathophysiology and management of thoracic injury; Pathophysiology and management of abdominal injury; Management of vascular injuries; Management of limb and pelvic injuries; Assessment and management of fat embolism; Assessment and management of combat trauma; Part 16.2: Ballistic trauma; Pathophysiology of ballistic trauma; Assessment and management of ballistic trauma; Part 16.3: Traumatic brain injury; Epidemiology and pathophysiology of traumatic brain injury; Assessment of traumatic brain injury; Management of traumatic brain injury; Part 16.4 Spinal cord injury; Assessment and immediate management of spinal cord injury; Ongoing management of the tetraplegic patient in the ICU; Part 16.5: Burns; Pathophysiology and assessment of burns; Management of burns in the ICU; Section 17: Physical Disorders; Part 17.1: Drowning; Pathophysiology and management of drowning; Part 17.2: Electrocoution; Pathophysiology and management of electrocution; Part 17.3: Altitude- and depth-related disorders; Pathophysiology and management of altitude related disorders; Pathophysiology and management of depth related disorders; Pathophysiology and management of fever; Pathophysiology and management of hyperthermia; Pathophysiology and management of hypothermia; Part 17.4: Rhabdomyolysis; Pathophysiology and management of rhabdomyolysis; Section 18: Pain and Sedation; Part 18.1: Pain; Pathophysiology and assessment of pain; Pain management in the critically ill; Part 18.2: Sedation; Sedation assessment in the critically ill; Management of sedation in the critically ill; Section 19: General Surgical and Obstetric Intensive Care; Part 19.1: Optimisation strategies for the high-risk surgical patient; Identification of the high-risk surgical patient; Peri-operative optimisation of the high risk surgical patient; Part 19.2: General post-operative intensive care; Post-operative ventilatory dysfunction management in the ICU; Post-operative fluid and circulatory management in the ICU; Surgical enhanced recovery programmes in the ICU; Part 19.3: Obstetric intensive care; Obstetric physiology and special considerations in ICU; Pathophysiology and management of pre-eclampsia, eclampsia and HELLP syndrome; Pathophysiology and management of critical illness in pregnancy; Section 20: Specialized Intensive Care; Part 20.1: Specialized surgical intensive care; Intensive care management after cardiothoracic surgery; Intensive care management after neurosurgery; Intensive care management after vascular surgery; Intensive care management in hepatic and other abdominal organ transplantation; Intensive care management in cardiac transplantation; Intensive care management in lung transplantation; Part 20.2: Oncological intensive care; ICU selection and outcome of patients with haematologic malignancy; Management of the bone marrow transplant recipient in ICU; Management of oncological complications in the ICU; Section 21: Recovery From Critical Illness; Part 21.1: In hospital recovery from critical illness; Chronic critical illness; Promoting physical recovery in critical illness; Promoting renal recovery in critical illness; Recovering from critical illness in hospital; Part 21.2: Complications of critical illness; Physical consequences of critical illness; Neurocognitive impairment after critical illness; Affective and mood disorders after critical illness; Part 21.3: Out-of-hospital support after critical illness; Long-term weaning centres in critical care; The ICU survivor clinic; Rehabilitation from critical illness after hospital discharge; Section 22: End Of Life Care; Part 22.1: Withdrawing and withholding treatment; Ethical decision making in withdrawing and withholding treatment; Management of the dying patient; Part 22.2: Management of the potential organ donor; Beating heart organ donation; Non-beating heart organ donation; Part 22.3: Post-mortem diagnosis; Post-mortem examination in the ICU;
Komentarze (0)